GE vs TCRX · P/E 44, rev $13.35B vs rev $2.0M
GE Aerospace (GE) versus Tscan Therapeutics Inc (TCRX) — a side-by-side from cached financials, not a winner call.
GE Aerospace (GE) is a aerospace & defense company listed on NYSE. It is led by H. Lawrence Culp Jr..
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
Latest reported GE revenue for 2026-06-30 was $13.35B. Net income was $2.37B. Revenue was up 7.7% from 2026-03-31 to 2026-06-30. GE currently screens at market cap $373.04B and trailing P/E 44.4.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
GE currently screens at market cap $373.04B and trailing P/E 44.4. TCRX currently screens at market cap $62.1M.
Not investment advice. Open the GE and TCRX stock pages for the full models.
Not investment advice.